Gynecologic Cancer News

Past-year Pap smear testing rates were lower in 2022 than in 2019, highlighting the need to increase screening access, especially in rural areas, to prevent cervical cancer, researchers reported in JAMA Network Open.

The FDA approved the use of pembrolizumab in combination with chemotherapy for adults with primary advanced or recurrent endometrial carcinoma.

An analysis of the online conversations of more than 1,000 health care professionals worldwide through May revealed positive reactions to the approval of three key treatment options for patients with cancer.

BOSTON — People with primary ovarian insufficiency have higher risk for breast cancer and borderline increased risk for ovarian cancer compared with the general population, and risks for some cancers extend to their relatives, data show.

Endometriosis was significantly associated with higher risks for both ovarian and endometrial cancers, but was not significantly associated with cervical cancer risk, according to an analysis published in Current Oncology.

A trial investigating mirvetuximab soravtansine monotherapy in certain patients with platinum-sensitive ovarian cancer met its primary endpoint of improved objective response rate, according to the agent’s manufacturer.

CHICAGO — Glucagon-like peptide-1 receptor agonists lowered the risk for obesity-related cancers compared with bariatric surgery among individuals with a BMI of at least 35, according to data presented at ASCO Annual Meeting.

Satish Gopal, MD, MPH, feels honored to receive this year’s ASCO Humanitarian Award.

Participation in cancer-related clinical trials could increase dramatically if researchers screened and recruited individuals using routine care patient-reported outcomes, according to results published in JAMA Oncology.

CHICAGO — Cancer risk among women varied based on the type of menopausal hormone therapy they used, according to randomized study results scheduled for presentation at ASCO Annual Meeting.